Biden Administration Unveils Advanced 'Error-Free Cancer Cell Surgery' Program

The Biden administration has launched a new program aimed at assisting surgeons in identifying and removing cancer cells without harming surrounding tissues. This is the first multi-billion dollar cancer-focused initiative of the government's Advanced Research Projects Agency for Health, known as ARPA-H. President Joe Biden initiated this program last year to foster advancements in cancer prevention, detection, and treatment. The program offers new proposals for developing devices and innovative technologies to enhance cancer identification and healthy tissue during surgery. The White House states that multiple awards are planned for this purpose, and the amount of resources will depend on the quality of the proposals received and the availability of funding. Mr. Biden stated, "This is an exciting chapter in cancer research and development that could save many lives and extend their longevity." In a tweet, Mr. Biden mentioned that the White House's cancer initiative will be transformative for Americans and people around the world. Surgery is often the first treatment option for over 2 million Americans diagnosed with cancer each year. However, current technologies do not allow doctors to easily and completely identify cancer cells from surrounding healthy tissue in the operating room. The U.S. government claims this barrier leads to multiple surgeries, more difficult recovery processes, cancer recurrence, and higher healthcare costs. New technologies will also help surgeons identify vital structures such as nerves, blood vessels, and lymph nodes that may be mistakenly harmed during invasive surgery. These new technologies will enable surgeons to visualize tumor margins during surgery and completely remove them. These tools could include devices that provide internal imaging. The program also seeks to develop devices that surgeons can use for clear three-dimensional anatomical visualization during operations. Eliana Hanko, ARPA-H program director, states that this program will ultimately transform surgical practices and for the first time allow for error-free resolution of issues. She added that the developed technologies could later be applied to a broader range of diseases. In 2016, President Biden launched a program called the "Cancer Moonshot," inspired by the U.S. moon landing in the 1960s, aimed at halving cancer mortality rates by 2047 and preventing over 4 million cancer deaths. This program also seeks to improve the experience of cancer patients and their families and caregivers. Congress has allocated $1.8 billion for this program, and the President's request for additional funding indicates bipartisan support for maintaining it. Biden's "Moonshot" program, which also funds the new initiative, ensures that new cancer surgery technologies will be accessible in rural areas. The White House Office of Science and Technology states that the new program could significantly improve cancer treatments and develop scientific advancements that currently have unknown applications. Dr. Arati Prabhakar, in an interview with the Associated Press, stated that since the program aims to achieve things that are not currently obvious or feasible, it must be risk-taking. She also added that the overall success of the program is the goal, even if some technologies face failure. Daniel Carnival, director of the White House Cancer Moonshot program, called this agency the "cornerstone" of government efforts to achieve cancer mortality reduction goals. He noted that this program has also issued an open call for other research projects. This report was compiled using the official ARPA-H website and sources such as the Associated Press and PBS.